Explore

AGBS2018

2018 Annual Global Biotech Summit

9 Science Park West Avenue, Hong Kong Science Park, Shatin,, Hong Kong
20 - 24 September 2018
The conference ended on 24 September 2018

Important Dates

Abstract Submission Deadline
1st August 2018
Early Bird Deadline
1st August 2018
Final Abstract / Full Paper Deadline
13th August 2018
Abstract Acceptance Notification
15th August 2018

About AGBS2018

This summit will gather investors, stakeholders, government officials, global leaders coming from worldwide and China to share the latest developments and potential business opportunities in biotechnology. A global investment forum will be included, providing a chance and platform to meet and connect with academics, researchers, biotech startups, financial institutions, decision makers from the Government and representatives from different biotech companies. Due to the new listing regime for emerging and innovative biotech companies proposed by Hong Kong Stock Exchange recently, this is an exciting moment, so seize this precious experience to personally view the future of biotechnology in the GBA.

Topics

Cancer, Molecular biochemistry, Molecular biology, Stem cell research, Antibiotics, Diagnostics and staging, Biotechnology • industrial microbiology and biotechnology • bioinformatics • system biology • chemical engineering • biomedical engineering, Next-gen sequencing informatics, Diagnosis and therapy of cancer, Medicine and diagnostics, Biomarkers and diagnostics, Traditional medicine today: clinical and research issues, Antibodies

Call for Papers

We are calling for new symposia ideas that meet this conference theme. Contributions to symposia are vetted by the symposium organizer, and curated so they complement each other.  Examples of topics include, but are not limited to:

  1.   Medical Devices
  • Wearable devices
  • Robotics
  • Bioelectronics

2.      Biomarker

  • Liquid Biopsy
  • Genetic Testing
  • Antibodies

3.      Point-of-care Diagnostics

  • Molecular Diagnostics
  • Next Generation Sequencing based-diagnostics
  • Molecular Diagnostics for Infectious Disease
  • Telehealth: improving access at the point-of-care
  • Point-of-care in the pharmacy
  • Emerging Point-of-care Diagnostics
  • Integrating point-of-care testing into health systems

4.      Regenerative Medicine

  • Cellular Therapies
  • Tissue Engineering and Biomaterials
  • Medical Devices and Artificial Organs

5.      Precision Medicine

  • Genome Sequence
  • Gene Therapy
  • o    Microbiome Composition
  • o    Big Data Analytics for Precision Medicine
  • o    Cancer Immunotherapy

6.      Chinese Medicine

  • o    Herbal Medicine
  • o    Traditional Chinese Medicine

7.      Next Generation Sequencing

  • o    Big data analysis for NGS
  • o    Applications of NGS technologies

8.      Drug Development & Discovery

  • o    Anti-Infectives
  • o    Clinical Trials and Regulatory Affairs
  • o    CNS Drug Discovery & Therapy
  • o    Drug Discovery in Preclinical Research
  • o    Genomics
  • o    Inflammation and Immunology
  • o    Vaccinations
  • o    Antibiotics

9.      Stem Cells

  • o    Applications for use
  • o    Therapies

10.  Genetics

  • o    Genetic testing
  • o    Genetic modification

11.  Cancer

  • o    Angiogenesis
  • o    Cancer Targeted Drug
  • o    Circulating Tumour Cells and Liquid Biopsy

12.  Pharmacology

  • o    Toxicology
  • o    Pharrmacovigilance and Drug Safety

13.  Lab-on-a-Chip

14.  The Golden Opportunities for Biotechnology of Greater Bay Area

15.  Others

Keep Up to Date with PaperCrowd

Sign up and follow your favorite conferences.

We are no longer accepting conference submissions on PaperCrowd. We apologise for any inconvenience.